175 related articles for article (PubMed ID: 11981740)
1. Progressive cutaneous hyalohyphomycosis due to Paecilomyces lilacinus: rapid response to treatment with caspofungin and itraconazole.
Safdar A
Clin Infect Dis; 2002 May; 34(10):1415-7. PubMed ID: 11981740
[TBL] [Abstract][Full Text] [Related]
2. Caspofungin in combination with itraconazole for the treatment of invasive aspergillosis in humans.
Rubin MA; Carroll KC; Cahill BC
Clin Infect Dis; 2002 Apr; 34(8):1160-1. PubMed ID: 11915012
[No Abstract] [Full Text] [Related]
3. Cutaneous hyalohyphomycosis caused by Paecilomyces lilacinus in an immunocompetent host successfully treated with itraconazole: case report and review.
Gutiérrez-Rodero F; Moragón M; Ortiz de la Tabla V; Mayol MJ; Martín C
Eur J Clin Microbiol Infect Dis; 1999 Nov; 18(11):814-8. PubMed ID: 10614958
[TBL] [Abstract][Full Text] [Related]
4. Update on antifungal therapy.
Grooters AM; Taboada J
Vet Clin North Am Small Anim Pract; 2003 Jul; 33(4):749-58, vi. PubMed ID: 12910741
[TBL] [Abstract][Full Text] [Related]
5. [New developments in antifungal therapy: fluconazole, itraconazole, voriconazole, caspofungin].
van 't Wout JW; Kuijper EJ; Verweij PE; Kullberg BJ
Ned Tijdschr Geneeskd; 2004 Aug; 148(34):1679-84. PubMed ID: 15453120
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous hyalohyphomycosis caused by Paecilomyces lilacinus: report of three cases and review of the literature.
Hall VC; Goyal S; Davis MD; Walsh JS
Int J Dermatol; 2004 Sep; 43(9):648-53. PubMed ID: 15357743
[TBL] [Abstract][Full Text] [Related]
7. Case report. Successful treatment of cutaneous Paecilomyces lilacinus infection with oral itraconazole in an immune competent host.
Gottlieb T; Atkins BL
Mycoses; 2001 Dec; 44(11-12):513-5. PubMed ID: 11820267
[TBL] [Abstract][Full Text] [Related]
8. Breakthrough trichosporonosis in a bone marrow transplant recipient receiving caspofungin acetate.
Goodman D; Pamer E; Jakubowski A; Morris C; Sepkowitz K
Clin Infect Dis; 2002 Aug; 35(3):E35-6. PubMed ID: 12115115
[TBL] [Abstract][Full Text] [Related]
9. Caspofungin: the first of a new class of antifungal agents.
Valgus JM
Cancer Pract; 2001; 9(6):314-6. PubMed ID: 11879335
[No Abstract] [Full Text] [Related]
10. New antifungal agents-treatment standards are beginning to grow old.
Maschmeyer G
J Antimicrob Chemother; 2002 Feb; 49(2):239-41. PubMed ID: 11815563
[No Abstract] [Full Text] [Related]
11. Resolution of fungemia due to Fusarium species in a patient with acute leukemia treated with caspofungin.
Apostolidis J; Bouzani M; Platsouka E; Belasiotou H; Stamouli M; Harhalakis N; Boutati EI; Paniara O; Nikiforakis E
Clin Infect Dis; 2003 May; 36(10):1349-50. PubMed ID: 12746788
[No Abstract] [Full Text] [Related]
12. Combination therapy with caspofungin and amphotericin B lipid complex.
Lum LR; Turco TF; Leone J
Am J Health Syst Pharm; 2002 Jan; 59(1):80-1. PubMed ID: 11813474
[No Abstract] [Full Text] [Related]
13. Paecilomyces lilacinus infection with a sporotrichoid pattern in a renal transplant patient.
Lott ME; Sheehan DJ; Davis LS
J Drugs Dermatol; 2007 Apr; 6(4):436-9. PubMed ID: 17668542
[TBL] [Abstract][Full Text] [Related]
14. Paecilomyces lilacinus cutaneous infection associated with peripherally inserted central catheter insertion.
Lin WL; Lin WC; Chiu CS
J Eur Acad Dermatol Venereol; 2008 Nov; 22(10):1267-8. PubMed ID: 18331302
[No Abstract] [Full Text] [Related]
15. [The future of antifungal agents].
Maesaki S
Rinsho Ketsueki; 2007 Jan; 48(1):26-35. PubMed ID: 17313074
[No Abstract] [Full Text] [Related]
16. Caspofungin in the treatment of oropharyngeal candidiasis.
Garbino J; Lew D; Hirschel B; Rohner P
Int J Clin Pract; 2003 Mar; 57(2):143-4. PubMed ID: 12661800
[TBL] [Abstract][Full Text] [Related]
17. Federal Drug Administration panel recommends approval of Cancidas, Merck's investigational antifungal drug.
J Assoc Nurses AIDS Care; 2001; 12(4):93-4. PubMed ID: 11486726
[No Abstract] [Full Text] [Related]
18. Caspofungin. L 743872, MK 0991, MK 991.
Drugs R D; 1999 Feb; 1(2):165-7. PubMed ID: 10566014
[No Abstract] [Full Text] [Related]
19. Caspofungin.
Chandrasekar PH; Manavathu EK
Drugs Today (Barc); 2002 Dec; 38(12):829-46. PubMed ID: 12582472
[TBL] [Abstract][Full Text] [Related]
20. In vitro evaluation of cytochrome P450-mediated drug interactions between cytarabine, idarubicin, itraconazole and caspofungin.
Colburn DE; Giles FJ; Oladovich D; Smith JA
Hematology; 2004 Jun; 9(3):217-21. PubMed ID: 15204103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
